NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. [electronic resource]
Producer: 20190214Description: 1416-1422 p. digitalISSN:- 1095-9203
- Aminopyridines -- pharmacology
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis
- Benzimidazoles -- pharmacology
- Cellular Senescence
- Cyclin-Dependent Kinase 4 -- antagonists & inhibitors
- Cyclin-Dependent Kinase 6 -- antagonists & inhibitors
- Cytostatic Agents -- pharmacology
- Cytotoxicity, Immunologic
- Humans
- Immunologic Surveillance
- Intercellular Adhesion Molecule-1 -- metabolism
- Killer Cells, Natural -- immunology
- Lung Neoplasms -- drug therapy
- Mice
- Mice, Inbred C57BL
- Mitogen-Activated Protein Kinases
- Molecular Targeted Therapy
- Mutation
- Piperazines -- pharmacology
- Proto-Oncogene Proteins p21(ras) -- genetics
- Purines -- pharmacology
- Pyridines -- pharmacology
- Pyridones -- pharmacology
- Pyrimidinones -- pharmacology
- Retinoblastoma Protein -- metabolism
- Tumor Necrosis Factor-alpha -- metabolism
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.